Ask AI
ProCE Banner Activity

IgG4-RD Expert Think Tank: Ensuring Timely Diagnosis and Evidence-Based Treatment to Prevent Relapse and Improve QoL

Podcast

Diagnosing and managing IgG4-related disease (IgG4-RD) requires a systematic and multidisciplinary approach to patient care. Learn how patients with IgG4-RD generally present across practice settings, the importance of ruling out key mimicking diseases and assessing multiorgan involvement, as well as evidence-based treatment strategies to prevent relapse and irreversible organ damage.

Released: October 16, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

This activity is supported by educational funding provided by Amgen.

Amgen

Target Audience

This activity is intended for gastroenterologists, rheumatologists, nephrologists, primary care physicians, NPs, and PAs caring for patients with IgG4-RD. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the multisystem clinical manifestations and evidence-based classification criteria used in the diagnosis of IgG4-RD

  • Select evidence-based treatment strategies for IgG4-RD based on clinical phenotype, relapse risk, and available efficacy and safety data

  • Develop multidisciplinary management strategies for IgG4-RD that support coordinated care, relapse monitoring, and glucocorticoid-sparing approaches